Medical Patent News

RSS

Third Wave Technologies issued "Invasive Cleavage of Nucleic Acids" patent

Third Wave Technologies has announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,011,944, entitled "Invasive Cleavage of Nucleic Acids," to the company.

17 Mar 2006

Sentillion sues for patent infringement

Sentillion, Inc., has announced that it has filed a patent infringement lawsuit against Carefx Corporation in the United States District Court of Delaware.

17 Mar 2006

HemoCue wins patent infringement suit

For more than two years, HemoCue AB and EKF-diagnostics GmbH, a company in Magdeburg, Germany, have been involved in a patent infringement suit.

14 Mar 2006

AstraZeneca starts patent infringement litigation against IVAX

AstraZeneca announced today that it has filed a lawsuit in the United States District Court for the District of New Jersey against IVAX Corporation, IVAX Pharmaceuticals and Zenith Laboratories

8 Mar 2006

GenoMed awarded second patent, for avoiding dialysis in acute kidney failure

GenoMed announced today that it received its second patent (US Patent #6,998,404) for the "Treatment or prevention of acute renal failure." Acute kidney failure usually happens when a patient gets dehydrated.

1 Mar 2006

BrainLAB wins patent infringement case

On Friday, the U.S. District Court in Denver, Colorado, dismissed the patent infringement lawsuit filed by Medtronic against BrainLAB in 1998.

27 Feb 2006

Takeda wins patent infringement case

Takeda Pharmaceutical Company Limited and its wholly owned subsidiary, Takeda Pharmaceuticals North America, Inc. have announced that Takeda's intellectual property rights have been successfully asserted against generic manufacturers seeking to challenge Takeda's patent rights to ACTOS (pioglitazone HCl).

24 Feb 2006

Angiotech to appeal judgement regarding UK patent

Angiotech Pharmaceuticals has announced that it intends to appeal a UK trial court decision to revoke Angiotech's UK designation of its European Patent No. 0,706,376.

24 Feb 2006

Sentillion issued U.S. patent for technology for managing context sharing systems

Sentillion, Inc., the leading provider of identity and access management (IAM) solutions for the always-on healthcare industry, has received its third patent (U.S. Patent No. 6,993,556) from the United States Patent and Trademark Office.

21 Feb 2006

Oncolytics Biotech granted new patent

Oncolytics Biotech Inc. has been granted U.S. Patent 6,994,858 entitled "Reovirus Clearance of Ras-Mediated Neoplastic Cells from Mixed Cellular Compositions."

7 Feb 2006

Laserscope issued new U.S. patent

Laserscope announced today that it has been issued an important U.S. patent from the United States Patent and Trademark Office (USPTO) relating to the use of its Photoselective Vaporization (PV) method and technology for therapeutic treatment of benign prostatic hyperplasia (BPH) and other tissues in the human body.

26 Jan 2006

Patent losses open up $30 billion biologics market to generic competition

With powerhouse biologics, such as human growth hormone and insulin, losing their U.S. patent protection in 2005 and many more set to expire within the next 4 years, generic competition in the lucrative biopharmaceutical market is imminent, according to a new study from Kalorama Information.

25 Jan 2006

Sirna Therapeutics awarded patent covering large-scale synthesis of RNAi-based therapeutics

Sirna Therapeutics has announced that the United States Patent and Trademark Office (USPTO) has granted Sirna U.S. Patent No. 6,989,442 for the chemical synthesis and manufacturing of ribonucleic acids (RNA).

25 Jan 2006

Advanced Biomaterial Systems receives U.S. patent for mixing and dispensing apparatus

Advanced Biomaterial Systems, Inc. (ABS) has received U.S. patent 6,984,063 for an Apparatus for Mixing and Dispensing Components. This patent is a continuation of several patents which incorporate twistOR and Plexis technology.

23 Jan 2006

Morphotek issued patent covering the use of chemical inhibitors of mismatch repair

Morphotek Inc. announced today the issuance of United States Patent 6,982,169 covering the use of chemical inhibitors to enhance evolution of target host cell genomes by reversibly regulating mismatch repair (MMR) in vivo.

23 Jan 2006

QLT announces trial court decision in ongoing Eligard( patent litigation

QLT Inc. has announced a ruling in the on-going litigation between plaintiff TAP Pharmaceutical Products, Inc. and its co-plaintiffs and defendants QLT USA, Inc. and Sanofi-Synthelabo Inc., a member of the Sanofi-aventis Group.

23 Jan 2006

Nanogen issued patent relating to synthetic polymer hydrogels

Nanogen has announced it was issued Patent No. 6,960,298, "Mesoporous permeation layers for use on active electronic matrix devices" by the U.S. Patent and Trademark Office.

8 Nov 2005

CSIRO's RNAi 'gene silencing' patents strengthened

The patent landscape for RNAi 'gene silencing' - including CSIRO's hairpin RNAi technology - has been significantly clarified following the resolution of several opposition and re-examination cases in Australia.

26 Oct 2005

Third Wave Technologies files patent suits against Chiron and Bayer

The company last Friday filed suit against Digene Corp., seeking a court ruling supporting Third Wave's right to sell its human papilloma virus (HPV) products. Third Wave today also filed suit against Chiron Corp., Bayer Corp., and Bayer HealthCare LLC asking for a similar ruling about its right to sell its hepatitis C virus products.

11 Oct 2005

Nabi Biopharmaceuticals granted Staphylococcus Antigen and Vaccine patent

Nabi Biopharmaceuticals has announced that it has been granted U.S. Patent No. 6,936,258 entitled "Staphylococcus Antigen and Vaccine" by the U.S. Patent and Trademark Office for the composition of a strategically important glycoprotein-based antigen (GP-1) associated with three Staphylococcal strains: S. epidermidis, S. haemolyticus and S. hominis.

11 Oct 2005